NETWORKING RECEPTION - POSTERS, EXHIBITS AND HUBTALKS
HT-5 - OPTIMIZING PATIENT OUTCOMES: EFFICACY-DRIVEN IMPROVEMENTS IN QUALITY OF LIFE FOR ATTR AMYLOIDOSIS
Thursday, October 23, 2025
5:30pm - 5:50pm ET
Room: Theatre 2
Sponsored By
Gain practical insights into improving the care of patients living with ATTR amyloidosis. This session will explore how disease burden extends beyond cardiac and neurological function to significantly affect patients' daily experiences and well-being. Learn how emerging clinical evidence is reshaping our understanding of quality of life in ATTR amyloidosis and informing patient-centered approaches. Drawing on real-world scenarios, this session will equip you with practical strategies to evaluate new data, guide personalized management decisions, and provide more holistic, patient-centered care throughout the entire ATTR journey.
Learning Objectives:
At the end of this session participants will be able to:
Understand the clinical burden and patient quality of life challenges associated with ATTR amyloidosis;
Review the latest clinical evidence on disease-modifying therapies for ATTR amyloidosis, emphasizing their impact on patient-reported outcomes and functional improvements; and
Discuss strategies for integrating efficacy data into daily clinical decision-making to improve long-term patient outcomes.
